- call +1-201-465-4211
- email sales@marketsandresearch.biz
- Call +1-201-465-4211
- Email: sales@marketsandresearch.biz
COVID-19, the disease it causes, surfaced in late 2019, and now had become a full-blown crisis worldwide. Over fifty key countries had declared a national emergency to combat coronavirus. With cases spreading, and the epicentre of the outbreak shifting to Europe, North America, India and Latin America, life in these regions has been upended the way it had been in Asia earlier in the developing crisis. As the coronavirus pandemic has worsened, the entertainment industry has been upended along with most every other facet of life. As experts work toward a better understanding, the world shudders in fear of the unknown, a worry that has rocked global financial markets, leading to daily volatility in the U.S. stock markets.
According to this latest study, the 2020 growth of Rabies Immune Globulin will have significant change from previous year. By the most conservative estimates of global Rabies Immune Globulin market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. We give this scenario a XX% probability, where under the scenario the supply chain will start to recover and quarantines and travel bans will ease, over the Q2. Longer-term, the effect of COVID-19 will be felt throughout the year with some degree of harm done by the virus. Over the next five years the Rabies Immune Globulin market will register a XX% CAGR in terms of revenue, the global market size will reach US$ XX million by 2025.
This report presents a comprehensive overview, market shares, and growth opportunities of Rabies Immune Globulin market by product type, application, key manufacturers and key regions and countries.
This study specially analyses the impact of Covid-19 outbreak on the Rabies Immune Globulin, covering the supply chain analysis, impact assessment to the Rabies Immune Globulin market size growth rate in several scenarios, and the measures to be undertaken by Rabies Immune Globulin companies in response to the COVID-19 epidemic.
Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.
ERIG
HRIG
Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.
Category II Exposure
Category III Exposure
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
CSL Behring
Shanghai RAAS
Grifols
Sichuan Yuanda Shuyang
CNBG
Sanofi
Shuanglin Bio
Kamada
Weiguang Bio
CBPO
Bharat Serum
VINS
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Rabies Immune Globulin consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Rabies Immune Globulin market by identifying its various subsegments.
Focuses on the key global Rabies Immune Globulin manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Rabies Immune Globulin with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Rabies Immune Globulin submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 What is the Impact of Covid-19 Outbreak On the Rabies Immune Globulin?
1.8.1 Optimistic Scenario: COVID-19 Is Contained by May or June, with Normalcy Returning to Global Operations Through the End of Q2.
1.8.2 Conservative Scenario: COVID-19 Remains Prevalent, with Continued Impacts Lasting Into Q4.
1.8.3 Estimated Impact of the Coronavirus (COVID-19) Epidemic on the Global Rabies Immune Globulin Market Size in 2020, by Scenario
1.8.4 Corporate Strategy the Manufacturers Should Be Thinking About Right Now
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Rabies Immune Globulin Consumption 2015-2025
2.1.2 Rabies Immune Globulin Consumption CAGR by Region
2.2 Rabies Immune Globulin Segment by Type
2.2.1 ERIG
2.2.2 HRIG
2.3 Rabies Immune Globulin Consumption by Type
2.3.1 Global Rabies Immune Globulin Consumption Market Share by Type (2015-2020)
2.3.2 Global Rabies Immune Globulin Revenue and Market Share by Type (2015-2020)
2.3.3 Global Rabies Immune Globulin Sale Price by Type (2015-2020)
2.4 Rabies Immune Globulin Segment by Application
2.4.1 Category II Exposure
2.4.2 Category III Exposure
2.5 Rabies Immune Globulin Consumption by Application
2.5.1 Global Rabies Immune Globulin Consumption Market Share by Type (2015-2020)
2.5.2 Global Rabies Immune Globulin Value and Market Share by Type (2015-2020)
2.5.3 Global Rabies Immune Globulin Sale Price by Type (2015-2020)
3 Global Rabies Immune Globulin by Company
3.1 Global Rabies Immune Globulin Sales Market Share by Company
3.1.1 Global Rabies Immune Globulin Sales by Company (2018-2020)
3.1.2 Global Rabies Immune Globulin Sales Market Share by Company (2018-2020)
3.2 Global Rabies Immune Globulin Revenue Market Share by Company
3.2.1 Global Rabies Immune Globulin Revenue by Company (2018-2020)
3.2.2 Global Rabies Immune Globulin Revenue Market Share by Company (2018-2020)
3.3 Global Rabies Immune Globulin Sale Price by Company
3.4 Global Rabies Immune Globulin Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global Rabies Immune Globulin Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Rabies Immune Globulin Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Rabies Immune Globulin by Regions
4.1 Rabies Immune Globulin by Regions
4.2 Americas Rabies Immune Globulin Consumption Growth
4.3 APAC Rabies Immune Globulin Consumption Growth
4.4 Europe Rabies Immune Globulin Consumption Growth
4.5 Middle East & Africa Rabies Immune Globulin Consumption Growth
5 Americas
5.1 Americas Rabies Immune Globulin Consumption by Countries
5.1.1 Americas Rabies Immune Globulin Consumption by Countries (2015-2020)
5.1.2 Americas Rabies Immune Globulin Value by Countries (2015-2020)
5.2 Americas Rabies Immune Globulin Consumption by Type
5.3 Americas Rabies Immune Globulin Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Rabies Immune Globulin Consumption by Regions
6.1.1 APAC Rabies Immune Globulin Consumption by Regions (2015-2020)
6.1.2 APAC Rabies Immune Globulin Value by Regions (2015-2020)
6.2 APAC Rabies Immune Globulin Consumption by Type
6.3 APAC Rabies Immune Globulin Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions
7 Europe
7.1 Europe Rabies Immune Globulin by Countries
7.1.1 Europe Rabies Immune Globulin Consumption by Countries (2015-2020)
7.1.2 Europe Rabies Immune Globulin Value by Countries (2015-2020)
7.2 Europe Rabies Immune Globulin Consumption by Type
7.3 Europe Rabies Immune Globulin Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Rabies Immune Globulin by Countries
8.1.1 Middle East & Africa Rabies Immune Globulin Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Rabies Immune Globulin Value by Countries (2015-2020)
8.2 Middle East & Africa Rabies Immune Globulin Consumption by Type
8.3 Middle East & Africa Rabies Immune Globulin Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Rabies Immune Globulin Distributors
10.3 Rabies Immune Globulin Customer
11 Global Rabies Immune Globulin Market Forecast
11.1 Global Rabies Immune Globulin Consumption Forecast (2021-2025)
11.2 Global Rabies Immune Globulin Forecast by Regions
11.2.1 Global Rabies Immune Globulin Forecast by Regions (2021-2025)
11.2.2 Global Rabies Immune Globulin Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Rabies Immune Globulin Forecast by Type
11.8 Global Rabies Immune Globulin Forecast by Application
12 Key Players Analysis
12.1 CSL Behring
12.1.1 Company Information
12.1.2 Rabies Immune Globulin Product Offered
12.1.3 CSL Behring Rabies Immune Globulin Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 CSL Behring Latest Developments
12.2 Shanghai RAAS
12.2.1 Company Information
12.2.2 Rabies Immune Globulin Product Offered
12.2.3 Shanghai RAAS Rabies Immune Globulin Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 Shanghai RAAS Latest Developments
12.3 Grifols
12.3.1 Company Information
12.3.2 Rabies Immune Globulin Product Offered
12.3.3 Grifols Rabies Immune Globulin Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 Grifols Latest Developments
12.4 Sichuan Yuanda Shuyang
12.4.1 Company Information
12.4.2 Rabies Immune Globulin Product Offered
12.4.3 Sichuan Yuanda Shuyang Rabies Immune Globulin Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 Sichuan Yuanda Shuyang Latest Developments
12.5 CNBG
12.5.1 Company Information
12.5.2 Rabies Immune Globulin Product Offered
12.5.3 CNBG Rabies Immune Globulin Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 CNBG Latest Developments
12.6 Sanofi
12.6.1 Company Information
12.6.2 Rabies Immune Globulin Product Offered
12.6.3 Sanofi Rabies Immune Globulin Sales, Revenue, Price and Gross Margin (2018-2020)
12.6.4 Main Business Overview
12.6.5 Sanofi Latest Developments
12.7 Shuanglin Bio
12.7.1 Company Information
12.7.2 Rabies Immune Globulin Product Offered
12.7.3 Shuanglin Bio Rabies Immune Globulin Sales, Revenue, Price and Gross Margin (2018-2020)
12.7.4 Main Business Overview
12.7.5 Shuanglin Bio Latest Developments
12.8 Kamada
12.8.1 Company Information
12.8.2 Rabies Immune Globulin Product Offered
12.8.3 Kamada Rabies Immune Globulin Sales, Revenue, Price and Gross Margin (2018-2020)
12.8.4 Main Business Overview
12.8.5 Kamada Latest Developments
12.9 Weiguang Bio
12.9.1 Company Information
12.9.2 Rabies Immune Globulin Product Offered
12.9.3 Weiguang Bio Rabies Immune Globulin Sales, Revenue, Price and Gross Margin (2018-2020)
12.9.4 Main Business Overview
12.9.5 Weiguang Bio Latest Developments
12.10 CBPO
12.10.1 Company Information
12.10.2 Rabies Immune Globulin Product Offered
12.10.3 CBPO Rabies Immune Globulin Sales, Revenue, Price and Gross Margin (2018-2020)
12.10.4 Main Business Overview
12.10.5 CBPO Latest Developments
12.11 Bharat Serum
12.11.1 Company Information
12.11.2 Rabies Immune Globulin Product Offered
12.11.3 Bharat Serum Rabies Immune Globulin Sales, Revenue, Price and Gross Margin (2018-2020)
12.11.4 Main Business Overview
12.11.5 Bharat Serum Latest Developments
12.12 VINS
12.12.1 Company Information
12.12.2 Rabies Immune Globulin Product Offered
12.12.3 VINS Rabies Immune Globulin Sales, Revenue, Price and Gross Margin (2018-2020)
12.12.4 Main Business Overview
12.12.5 VINS Latest Developments
13 Research Findings and Conclusion
List of Tables
Table 1. Estimated Impact of the Coronavirus (COVID-19) Epidemic on the Global Rabies Immune Globulin Market Size in 2020, by Scenario
Table 2. COVID-19: Measures to be Undertaken by Rabies Immune Globulin Companies
Table 3. Research Methodology
Table 4. Data Source
Table 5. Rabies Immune Globulin Consumption CAGR by Region 2015-2025 ($ Millions)
Table 6. Major Players of ERIG
Table 7. Major Players of HRIG
Table 8. Global Consumption Sales by Type (2015-2020)
Table 9. Global Rabies Immune Globulin Consumption Market Share by Type (2015-2020)
Table 10. Global Rabies Immune Globulin Revenue by Type (2015-2020) ($ million)
Table 11. Global Rabies Immune Globulin Value Market Share by Type (2015-2020) ($ Millions)
Table 12. Global Rabies Immune Globulin Sale Price by Type (2015-2020)
Table 13. Global Consumption Sales by Application (2015-2020)
Table 14. Global Rabies Immune Globulin Consumption Market Share by Application (2015-2020)
Table 15. Global Rabies Immune Globulin Value by Application (2015-2020)
Table 16. Global Rabies Immune Globulin Value Market Share by Application (2015-2020)
Table 17. Global Rabies Immune Globulin Sale Price by Application (2015-2020)
Table 18. Global Rabies Immune Globulin Sales by Company (2017-2019) (K Units)
Table 19. Global Rabies Immune Globulin Sales Market Share by Company (2017-2019)
Table 20. Global Rabies Immune Globulin Revenue by Company (2017-2019) ($ Millions)
Table 21. Global Rabies Immune Globulin Revenue Market Share by Company (2017-2019)
Table 22. Global Rabies Immune Globulin Sale Price by Company (2017-2019)
Table 23. Global Rabies Immune Globulin Manufacturing Base Distribution and Sales Area by Manufacturers
Table 24. Players Rabies Immune Globulin Products Offered
Table 25. Rabies Immune Globulin Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
Table 26. Global Rabies Immune Globulin Consumption by Regions 2015-2020 (K Units)
Table 27. Global Rabies Immune Globulin Consumption Market Share by Regions 2015-2020
Table 28. Global Rabies Immune Globulin Value by Regions 2015-2020 ($ Millions)
Table 29. Global Rabies Immune Globulin Value Market Share by Regions 2015-2020
Table 30. Americas Rabies Immune Globulin Consumption by Countries (2015-2020) (K Units)
Table 31. Americas Rabies Immune Globulin Consumption Market Share by Countries (2015-2020)
Table 32. Americas Rabies Immune Globulin Value by Countries (2015-2020) ($ Millions)
Table 33. Americas Rabies Immune Globulin Value Market Share by Countries (2015-2020)
Table 34. Americas Rabies Immune Globulin Consumption by Type (2015-2020) (K Units)
Table 35. Americas Rabies Immune Globulin Consumption Market Share by Type (2015-2020)
Table 36. Americas Rabies Immune Globulin Consumption by Application (2015-2020) (K Units)
Table 37. Americas Rabies Immune Globulin Consumption Market Share by Application (2015-2020)
Table 38. APAC Rabies Immune Globulin Consumption by Countries (2015-2020) (K Units)
Table 39. APAC Rabies Immune Globulin Consumption Market Share by Countries (2015-2020)
Table 40. APAC Rabies Immune Globulin Value by Regions (2015-2020) ($ Millions)
Table 41. APAC Rabies Immune Globulin Value Market Share by Regions (2015-2020)
Table 42. APAC Rabies Immune Globulin Consumption by Type (2015-2020) (K Units)
Table 43. APAC Rabies Immune Globulin Consumption Market Share by Type (2015-2020)
Table 44. APAC Rabies Immune Globulin Consumption by Application (2015-2020) (K Units)
Table 45. APAC Rabies Immune Globulin Consumption Market Share by Application (2015-2020)
Table 46. Europe Rabies Immune Globulin Consumption by Countries (2015-2020) (K Units)
Table 47. Europe Rabies Immune Globulin Consumption Market Share by Countries (2015-2020)
Table 48. Europe Rabies Immune Globulin Value by Countries (2015-2020) ($ Millions)
Table 49. Europe Rabies Immune Globulin Value Market Share by Countries (2015-2020)
Table 50. Europe Rabies Immune Globulin Consumption by Type (2015-2020) (K Units)
Table 51. Europe Rabies Immune Globulin Consumption Market Share by Type (2015-2020)
Table 52. Europe Rabies Immune Globulin Consumption by Application (2015-2020) (K Units)
Table 53. Europe Rabies Immune Globulin Consumption Market Share by Application (2015-2020)
Table 54. Middle East & Africa Rabies Immune Globulin Consumption by Countries (2015-2020) (K Units)
Table 55. Middle East & Africa Rabies Immune Globulin Consumption Market Share by Countries (2015-2020)
Table 56. Middle East & Africa Rabies Immune Globulin Value by Countries (2015-2020) ($ Millions)
Table 57. Middle East & Africa Rabies Immune Globulin Value Market Share by Countries (2015-2020)
Table 58. Middle East & Africa Rabies Immune Globulin Consumption by Type (2015-2020) (K Units)
Table 59. Middle East & Africa Rabies Immune Globulin Consumption Market Share by Type (2015-2020)
Table 60. Middle East & Africa Rabies Immune Globulin Consumption by Application (2015-2020) (K Units)
Table 61. Middle East & Africa Rabies Immune Globulin Consumption Market Share by Application (2015-2020)
Table 62. Rabies Immune Globulin Distributors List
Table 63. Rabies Immune Globulin Customer List
Table 64. Global Rabies Immune Globulin Consumption Forecast by Countries (2021-2025) (K Units)
Table 65. Global Rabies Immune Globulin Consumption Market Forecast by Regions
Table 66. Global Rabies Immune Globulin Value Forecast by Countries (2021-2025) ($ Millions)
Table 67. Global Rabies Immune Globulin Value Market Share Forecast by Regions
Table 68. Global Rabies Immune Globulin Consumption Forecast by Type (2021-2025) (K Units)
Table 69. Global Rabies Immune Globulin Consumption Market Share Forecast by Type (2021-2025)
Table 70. Global Rabies Immune Globulin Value Forecast by Type (2021-2025) ($ Millions)
Table 71. Global Rabies Immune Globulin Value Market Share Forecast by Type (2021-2025)
Table 72. Global Rabies Immune Globulin Consumption Forecast by Application (2021-2025) (K Units)
Table 73. Global Rabies Immune Globulin Consumption Market Share Forecast by Application (2021-2025)
Table 74. Global Rabies Immune Globulin Value Forecast by Application (2021-2025) ($ Millions)
Table 75. Global Rabies Immune Globulin Value Market Share Forecast by Application (2021-2025)
Table 76. CSL Behring Product Offered
Table 77. CSL Behring Rabies Immune Globulin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 78. CSL Behring Main Business
Table 79. CSL Behring Latest Developments
Table 80. CSL Behring Basic Information, Company Total Revenue (in $ million), Rabies Immune Globulin Manufacturing Base, Sales Area and Its Competitors
Table 81. Shanghai RAAS Product Offered
Table 82. Shanghai RAAS Rabies Immune Globulin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 83. Shanghai RAAS Main Business
Table 84. Shanghai RAAS Latest Developments
Table 85. Shanghai RAAS Basic Information, Company Total Revenue (in $ million), Rabies Immune Globulin Manufacturing Base, Sales Area and Its Competitors
Table 86. Grifols Product Offered
Table 87. Grifols Rabies Immune Globulin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 88. Grifols Main Business
Table 89. Grifols Latest Developments
Table 90. Grifols Basic Information, Company Total Revenue (in $ million), Rabies Immune Globulin Manufacturing Base, Sales Area and Its Competitors
Table 91. Sichuan Yuanda Shuyang Product Offered
Table 92. Sichuan Yuanda Shuyang Rabies Immune Globulin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 93. Sichuan Yuanda Shuyang Main Business
Table 94. Sichuan Yuanda Shuyang Latest Developments
Table 95. Sichuan Yuanda Shuyang Basic Information, Company Total Revenue (in $ million), Rabies Immune Globulin Manufacturing Base, Sales Area and Its Competitors
Table 96. CNBG Product Offered
Table 97. CNBG Rabies Immune Globulin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 98. CNBG Main Business
Table 99. CNBG Latest Developments
Table 100. CNBG Basic Information, Company Total Revenue (in $ million), Rabies Immune Globulin Manufacturing Base, Sales Area and Its Competitors
Table 101. Sanofi Product Offered
Table 102. Sanofi Rabies Immune Globulin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 103. Sanofi Main Business
Table 104. Sanofi Latest Developments
Table 105. Sanofi Basic Information, Company Total Revenue (in $ million), Rabies Immune Globulin Manufacturing Base, Sales Area and Its Competitors
Table 106. Shuanglin Bio Product Offered
Table 107. Shuanglin Bio Basic Information, Company Total Revenue (in $ million), Rabies Immune Globulin Manufacturing Base, Sales Area and Its Competitors
Table 108. Shuanglin Bio Main Business
Table 109. Shuanglin Bio Latest Developments
Table 110. Shuanglin Bio Rabies Immune Globulin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 111. Kamada Product Offered
Table 112. Kamada Rabies Immune Globulin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 113. Kamada Main Business
Table 114. Kamada Latest Developments
Table 115. Kamada Basic Information, Company Total Revenue (in $ million), Rabies Immune Globulin Manufacturing Base, Sales Area and Its Competitors
Table 116. Weiguang Bio Product Offered
Table 117. Weiguang Bio Rabies Immune Globulin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 118. Weiguang Bio Main Business
Table 119. Weiguang Bio Latest Developments
Table 120. Weiguang Bio Basic Information, Company Total Revenue (in $ million), Rabies Immune Globulin Manufacturing Base, Sales Area and Its Competitors
Table 121. CBPO Product Offered
Table 122. CBPO Rabies Immune Globulin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 123. CBPO Main Business
Table 124. CBPO Latest Developments
Table 125. CBPO Basic Information, Company Total Revenue (in $ million), Rabies Immune Globulin Manufacturing Base, Sales Area and Its Competitors
Table 126. Bharat Serum Product Offered
Table 127. Bharat Serum Rabies Immune Globulin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 128. Bharat Serum Main Business
Table 129. Bharat Serum Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 130. Bharat Serum Latest Developments
Table 131. VINS Product Offered
Table 132. VINS Rabies Immune Globulin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 133. VINS Main Business
Table 134. VINS Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 135. VINS Latest Developments
List of Figures
Figure 1. Picture of Rabies Immune Globulin
Figure 2. Rabies Immune Globulin Report Years Considered
Figure 3. Market Research Methodology
Figure 4. Global Rabies Immune Globulin Consumption Growth Rate 2015-2025 (K Units)
Figure 5. Global Rabies Immune Globulin Value Growth Rate 2015-2025 ($ Millions)
Figure 6. Product Picture of ERIG
Figure 7. Product Picture of HRIG
Figure 8. Global Rabies Immune Globulin Consumption Market Share by Type (2015-2020)
Figure 9. Global Rabies Immune Globulin Value Market Share by Type (2015-2020)
Figure 10. Rabies Immune Globulin Consumed in Category II Exposure
Figure 11. Global Rabies Immune Globulin Market: Category II Exposure (2015-2020) (K Units)
Figure 12. Global Rabies Immune Globulin Market: Category II Exposure (2015-2020) ($ Millions)
Figure 13. Rabies Immune Globulin Consumed in Category III Exposure
Figure 14. Global Rabies Immune Globulin Market: Category III Exposure (2015-2020) (K Units)
Figure 15. Global Rabies Immune Globulin Market: Category III Exposure (2015-2020) ($ Millions)
Figure 16. Global Rabies Immune Globulin Consumption Market Share by Application (2015-2020)
Figure 17. Global Rabies Immune Globulin Value Market Share by Application (2015-2020)
Figure 18. Global Rabies Immune Globulin Sales Market Share by Company in 2017
Figure 19. Global Rabies Immune Globulin Sales Market Share by Company in 2019
Figure 20. Global Rabies Immune Globulin Revenue Market Share by Company in 2017
Figure 21. Global Rabies Immune Globulin Revenue Market Share by Company in 2019
Figure 22. Global Rabies Immune Globulin Sale Price by Company in 2019
Figure 23. Global Rabies Immune Globulin Consumption Market Share by Regions 2015-2020
Figure 24. Global Rabies Immune Globulin Value Market Share by Regions 2015-2020
Figure 25. Americas Rabies Immune Globulin Consumption 2015-2020 (K Units)
Figure 26. Americas Rabies Immune Globulin Value 2015-2020 ($ Millions)
Figure 27. APAC Rabies Immune Globulin Consumption 2015-2020 (K Units)
Figure 28. APAC Rabies Immune Globulin Value 2015-2020 ($ Millions)
Figure 29. Europe Rabies Immune Globulin Consumption 2015-2020 (K Units)
Figure 30. Europe Rabies Immune Globulin Value 2015-2020 ($ Millions)
Figure 31. Middle East & Africa Rabies Immune Globulin Consumption 2015-2020 (K Units)
Figure 32. Middle East & Africa Rabies Immune Globulin Value 2015-2020 ($ Millions)
Figure 33. Americas Rabies Immune Globulin Consumption Market Share by Countries in 2019
Figure 34. Americas Rabies Immune Globulin Value Market Share by Countries in 2019
Figure 35. Americas Rabies Immune Globulin Consumption Market Share by Type in 2019
Figure 36. Americas Rabies Immune Globulin Consumption Market Share by Application in 2019
Figure 37. United States Rabies Immune Globulin Consumption Growth 2015-2020 (K Units)
Figure 38. United States Rabies Immune Globulin Value Growth 2015-2020 ($ Millions)
Figure 39. Canada Rabies Immune Globulin Consumption Growth 2015-2020 (K Units)
Figure 40. Canada Rabies Immune Globulin Value Growth 2015-2020 ($ Millions)
Figure 41. Mexico Rabies Immune Globulin Consumption Growth 2015-2020 (K Units)
Figure 42. Mexico Rabies Immune Globulin Value Growth 2015-2020 ($ Millions)
Figure 43. APAC Rabies Immune Globulin Consumption Market Share by Countries in 2019
Figure 44. APAC Rabies Immune Globulin Value Market Share by Regions in 2019
Figure 45. APAC Rabies Immune Globulin Consumption Market Share by Type in 2019
Figure 46. APAC Rabies Immune Globulin Consumption Market Share by Application in 2019
Figure 47. China Rabies Immune Globulin Consumption Growth 2015-2020 (K Units)
Figure 48. China Rabies Immune Globulin Value Growth 2015-2020 ($ Millions)
Figure 49. Japan Rabies Immune Globulin Consumption Growth 2015-2020 (K Units)
Figure 50. Japan Rabies Immune Globulin Value Growth 2015-2020 ($ Millions)
Figure 51. Korea Rabies Immune Globulin Consumption Growth 2015-2020 (K Units)
Figure 52. Korea Rabies Immune Globulin Value Growth 2015-2020 ($ Millions)
Figure 53. Southeast Asia Rabies Immune Globulin Consumption Growth 2015-2020 (K Units)
Figure 54. Southeast Asia Rabies Immune Globulin Value Growth 2015-2020 ($ Millions)
Figure 55. India Rabies Immune Globulin Consumption Growth 2015-2020 (K Units)
Figure 56. India Rabies Immune Globulin Value Growth 2015-2020 ($ Millions)
Figure 57. Australia Rabies Immune Globulin Consumption Growth 2015-2020 (K Units)
Figure 58. Australia Rabies Immune Globulin Value Growth 2015-2020 ($ Millions)
Figure 59. Europe Rabies Immune Globulin Consumption Market Share by Countries in 2019
Figure 60. Europe Rabies Immune Globulin Value Market Share by Countries in 2019
Figure 61. Europe Rabies Immune Globulin Consumption Market Share by Type in 2019
Figure 62. Europe Rabies Immune Globulin Consumption Market Share by Application in 2019
Figure 63. Germany Rabies Immune Globulin Consumption Growth 2015-2020 (K Units)
Figure 64. Germany Rabies Immune Globulin Value Growth 2015-2020 ($ Millions)
Figure 65. France Rabies Immune Globulin Consumption Growth 2015-2020 (K Units)
Figure 66. France Rabies Immune Globulin Value Growth 2015-2020 ($ Millions)
Figure 67. UK Rabies Immune Globulin Consumption Growth 2015-2020 (K Units)
Figure 68. UK Rabies Immune Globulin Value Growth 2015-2020 ($ Millions)
Figure 69. Italy Rabies Immune Globulin Consumption Growth 2015-2020 (K Units)
Figure 70. Italy Rabies Immune Globulin Value Growth 2015-2020 ($ Millions)
Figure 71. Russia Rabies Immune Globulin Consumption Growth 2015-2020 (K Units)
Figure 72. Russia Rabies Immune Globulin Value Growth 2015-2020 ($ Millions)
Figure 73. Middle East & Africa Rabies Immune Globulin Consumption Market Share by Countries in 2019
Figure 74. Middle East & Africa Rabies Immune Globulin Value Market Share by Countries in 2019
Figure 75. Middle East & Africa Rabies Immune Globulin Consumption Market Share by Type in 2019
Figure 76. Middle East & Africa Rabies Immune Globulin Consumption Market Share by Application in 2019
Figure 77. Egypt Rabies Immune Globulin Consumption Growth 2015-2020 (K Units)
Figure 78. Egypt Rabies Immune Globulin Value Growth 2015-2020 ($ Millions)
Figure 79. South Africa Rabies Immune Globulin Consumption Growth 2015-2020 (K Units)
Figure 80. South Africa Rabies Immune Globulin Value Growth 2015-2020 ($ Millions)
Figure 81. Israel Rabies Immune Globulin Consumption Growth 2015-2020 (K Units)
Figure 82. Israel Rabies Immune Globulin Value Growth 2015-2020 ($ Millions)
Figure 83. Turkey Rabies Immune Globulin Consumption Growth 2015-2020 (K Units)
Figure 84. Turkey Rabies Immune Globulin Value Growth 2015-2020 ($ Millions)
Figure 85. GCC Countries Rabies Immune Globulin Consumption Growth 2015-2020 (K Units)
Figure 86. GCC Countries Rabies Immune Globulin Value Growth 2015-2020 ($ Millions)
Figure 87. Global Rabies Immune Globulin Consumption Growth Rate Forecast (2021-2025) (K Units)
Figure 88. Global Rabies Immune Globulin Value Growth Rate Forecast (2021-2025) ($ Millions)
Figure 89. Americas Rabies Immune Globulin Consumption 2021-2025 (K Units)
Figure 90. Americas Rabies Immune Globulin Value 2021-2025 ($ Millions)
Figure 91. APAC Rabies Immune Globulin Consumption 2021-2025 (K Units)
Figure 92. APAC Rabies Immune Globulin Value 2021-2025 ($ Millions)
Figure 93. Europe Rabies Immune Globulin Consumption 2021-2025 (K Units)
Figure 94. Europe Rabies Immune Globulin Value 2021-2025 ($ Millions)
Figure 95. Middle East & Africa Rabies Immune Globulin Consumption 2021-2025 (K Units)
Figure 96. Middle East & Africa Rabies Immune Globulin Value 2021-2025 ($ Millions)
Figure 97. United States Rabies Immune Globulin Consumption 2021-2025 (K Units)
Figure 98. United States Rabies Immune Globulin Value 2021-2025 ($ Millions)
Figure 99. Canada Rabies Immune Globulin Consumption 2021-2025 (K Units)
Figure 100. Canada Rabies Immune Globulin Value 2021-2025 ($ Millions)
Figure 101. Mexico Rabies Immune Globulin Consumption 2021-2025 (K Units)
Figure 102. Mexico Rabies Immune Globulin Value 2021-2025 ($ Millions)
Figure 103. Brazil Rabies Immune Globulin Consumption 2021-2025 (K Units)
Figure 104. Brazil Rabies Immune Globulin Value 2021-2025 ($ Millions)
Figure 105. China Rabies Immune Globulin Consumption 2021-2025 (K Units)
Figure 106. China Rabies Immune Globulin Value 2021-2025 ($ Millions)
Figure 107. Japan Rabies Immune Globulin Consumption 2021-2025 (K Units)
Figure 108. Japan Rabies Immune Globulin Value 2021-2025 ($ Millions)
Figure 109. Korea Rabies Immune Globulin Consumption 2021-2025 (K Units)
Figure 110. Korea Rabies Immune Globulin Value 2021-2025 ($ Millions)
Figure 111. Southeast Asia Rabies Immune Globulin Consumption 2021-2025 (K Units)
Figure 112. Southeast Asia Rabies Immune Globulin Value 2021-2025 ($ Millions)
Figure 113. India Rabies Immune Globulin Consumption 2021-2025 (K Units)
Figure 114. India Rabies Immune Globulin Value 2021-2025 ($ Millions)
Figure 115. Australia Rabies Immune Globulin Consumption 2021-2025 (K Units)
Figure 116. Australia Rabies Immune Globulin Value 2021-2025 ($ Millions)
Figure 117. Germany Rabies Immune Globulin Consumption 2021-2025 (K Units)
Figure 118. Germany Rabies Immune Globulin Value 2021-2025 ($ Millions)
Figure 119. France Rabies Immune Globulin Consumption 2021-2025 (K Units)
Figure 120. France Rabies Immune Globulin Value 2021-2025 ($ Millions)
Figure 121. UK Rabies Immune Globulin Consumption 2021-2025 (K Units)
Figure 122. UK Rabies Immune Globulin Value 2021-2025 ($ Millions)
Figure 123. Italy Rabies Immune Globulin Consumption 2021-2025 (K Units)
Figure 124. Italy Rabies Immune Globulin Value 2021-2025 ($ Millions)
Figure 125. Russia Rabies Immune Globulin Consumption 2021-2025 (K Units)
Figure 126. Russia Rabies Immune Globulin Value 2021-2025 ($ Millions)
Figure 127. Spain Rabies Immune Globulin Consumption 2021-2025 (K Units)
Figure 128. Spain Rabies Immune Globulin Value 2021-2025 ($ Millions)
Figure 129. Egypt Rabies Immune Globulin Consumption 2021-2025 (K Units)
Figure 130. Egypt Rabies Immune Globulin Value 2021-2025 ($ Millions)
Figure 131. South Africa Rabies Immune Globulin Consumption 2021-2025 (K Units)
Figure 132. South Africa Rabies Immune Globulin Value 2021-2025 ($ Millions)
Figure 133. Israel Rabies Immune Globulin Consumption 2021-2025 (K Units)
Figure 134. Israel Rabies Immune Globulin Value 2021-2025 ($ Millions)
Figure 135. Turkey Rabies Immune Globulin Consumption 2021-2025 (K Units)
Figure 136. Turkey Rabies Immune Globulin Value 2021-2025 ($ Millions)
Figure 137. GCC Countries Rabies Immune Globulin Consumption 2021-2025 (K Units)
Figure 138. GCC Countries Rabies Immune Globulin Value 2021-2025 ($ Millions)
Figure 139. CSL Behring Rabies Immune Globulin Market Share (2018-2020)
Figure 140. Shanghai RAAS Rabies Immune Globulin Market Share (2018-2020)
Figure 141. Grifols Rabies Immune Globulin Market Share (2018-2020)
Figure 142. Sichuan Yuanda Shuyang Rabies Immune Globulin Market Share (2018-2020)
Figure 143. CNBG Rabies Immune Globulin Market Share (2018-2020)
Figure 144. Sanofi Rabies Immune Globulin Market Share (2018-2020)
Figure 145. Shuanglin Bio Rabies Immune Globulin Market Share (2018-2020)
Figure 146. Kamada Rabies Immune Globulin Market Share (2018-2020)
Figure 147. Weiguang Bio Rabies Immune Globulin Market Share (2018-2020)
Figure 148. CBPO Rabies Immune Globulin Market Share (2018-2020)
Figure 149. Bharat Serum Rabies Immune Globulin Market Share (2018-2020)
Figure 150. VINS Rabies Immune Globulin Market Share (2018-2020)
Please feel free to write an email to us or to use our electronic ticketing system.
